Ocular Therapeutix, Inc. (OCUL)
8.94
-0.65
(-6.78%)
USD |
NASDAQ |
Feb 27, 16:00
8.85
-0.09
(-1.01%)
After-Hours: 20:00
Ocular Therapeutix Research and Development Expense (TTM) : 197.10M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Abbott Laboratories | 2.89B |
| EyePoint Plc | 205.20M |
| Quince Therapeutics, Inc. | 28.61M |
| Ernexa Therapeutics, Inc. | 4.638M |